AVITA Medical, Inc. (RCEL:NASDAQ) closed at $13.41 on October 15, 2026, up 2.37% on the day. The stock trades 2.3% below its 52-week high of $13.73 and 316.5% above its 52-week low of $3.22. Over the past year, it gained 149.3%. AVITA Medical, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| +0.30% | +28.33% | +160.89% | +168.20% | +149.26% |
In 252 trading sessions since October 15, 2025, RCEL closed higher on 118 days (47%). Its best day was August 7, 2026 (+63.58%) and its worst was October 17, 2025 (-25.84%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 1 time.
Avita Medical is a single product company, the RECELL system, an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes thus avoiding or reducing the need for skin grafts. The device is approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft tissue wounds and vitiligo underway. It is currently in roll-out across the approximately 132 burn centres in the U.S. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories. It is expected to gain approval and launch in Japan via distribution partner Cosmotec shortly. In addition to its ASX listing, Avita listed on the Nasdaq in November 2019.
Find more stocks like RCEL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.